Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200?mg/m2).

MLA

Palumbo, A., et al. “Multiple Myeloma: Comparison of Two Dose-Intensive Melphalan Regimens (100 vs 200?Mg/M2).” Leukemia (08876924), vol. 18, no. 1, Jan. 2004, pp. 133–38. EBSCOhost, https://doi.org/10.1038/sj.leu.2403196.

APA

Palumbo, A., Bringhen, S., Bertola, A., Cavallo, F., Falco, P., Massaia, M., Bruno, B., Rus, C., Barbui, A., Caravita, T., Musto, P., Pescota, N., Rossini, F., Vignetti, M., & Boccadoro, M. (2004). Multiple myeloma: comparison of two dose-intensive melphalan regimens (100 vs 200?mg/m2). Leukemia (08876924), 18(1), 133–138. https://doi.org/10.1038/sj.leu.2403196

Chicago

Palumbo, A., S. Bringhen, A. Bertola, F. Cavallo, P. Falco, M. Massaia, B. Bruno, et al. 2004. “Multiple Myeloma: Comparison of Two Dose-Intensive Melphalan Regimens (100 vs 200?Mg/M2).” Leukemia (08876924) 18 (1): 133–38. doi:10.1038/sj.leu.2403196.